Nanomedicines for cancer immunotherapy

来源 :2016年中国药物制剂大会、中国药学会药剂专业委员会2016年学术年会、中国化学制药工业协会固体制剂专业委员会2016年 | 被引量 : 0次 | 上传用户:liyqi
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Immunotherapy has shown great promise in treating a variety of cancers,leading to durable responses and lifelong survival.Nanomedicine plays a vital role in improving drug delivery to tumors and tumor draining lymph node(TDLN)with favorable therapeutic efficacy and safety profile.
其他文献
会议
Purpose: The aim of this study was to improve solubility and dissolution of two BCS class II drugs,repaglinide(REP)and simvastatin(ST).
会议
会议
OBJECTIVE This study reports a promising approach to enhance the oral delivery of nuciferine(NUC),improve its aqueous solubility and bioavailability,and allow its controlled release as well as inhibit
Purpose:The aims of this study were to improve aqueous solubility and dissolution of poorly water-soluble ibuprofen(IBU)by cocrystallization technique and to investigate its solubility behavior and th
会议
会议
会议
会议
INTRODUCTION Magnetoliposomes,which are formed by encapsulating iron oxide nanoparticles within liposomes,have attracted interest.And magnetoliposomes are also potentially good multifunctional nanopla
会议
Solid lipid nanoparticles(SLNs)have been proposed as suitable colloidal carriers for delivery of drugs with limited solubility.In this work,KP-loaded SLNs were prepared,and the characteristics of the
会议